Professional Documents
Culture Documents
Adrenal
Adrenal
Increased lipolysis
Analytical methods
- Immunoassay
- HPLC
- GC-MS/ LC-MS
Choice of specimen:
- Urine – hormone/ metabolites- incompleteness of collection, altered renal
function
Hypofuction
• Addison’s disease
Cushing’s syndrome
• Result of autonomous, excessive production of cortisol leading to classic symptoms
characteristic of disorder
• Adrenal adenoma
• Adrenal carcinoma
• Iatrogenic
• Endogenous disorders- ACTH dependent/ ACTH independent
• Screening test:
- Uncommon disorder; common symptoms; early / mild stage-
demonstration of excessive and autonomous cortisol
production differential dx
1. Urinary free cortisol- <300 nmo/24 h normal; collection,;poor
specificity- +ve in pseudo cushing, obesity
2. Overnight low dose dexamethasone test- 1mg midnight- meas
of serum cortisol in morning- < 50 nmol/l; low specificity
3. Examining circadian rythm of cortisol secretion- morning night
difference lost- nocturnal concn inappropriately raised
2300h or 2400 h- <100 nmol/l normal
Differential diagnosis
1. ACTH measurement
• Low-adrenal cause
• Moderately elevated- Cushing syndrome
• Markedly elevated- ectopic ACTH secreting tumors
Clinical features:
• Hypertension (consequence of aldosterone induced
sodium retention)
• Muscle weakness
• Polydipsia, polyuria and nocturia
Diagnosis:
• Screening:
- Aldosterone
- Aldosterone to renin ratio
• Confirmation/ exclusion:
- Saline infusion test/ fludocortisone suppression test
• Other findings:
- Increased sodium
- Decreased potassium
Secondary aldosteronism:
• Due to incresed renin activity
• Far more common than primary form
• Increased renin activity leads to increased aldosterone
concentrations
• Patient may/ may not be hypertensive
• Conditions associated:
- Congestive cardiac failure
- Cirrhosis of liver, with ascites
- Nephrotic syndrome
- Others: renal artery stenosis, renin secreting tumor
• Differentiation between primary and secondary
aldosteronism:
- Plasma sodium
- renin
Addison’s disease
• Adrenal hypofunction
• Uncommon but life threatening condition
• Cause:
- Glucocorticoid treatment
- Autoimmune adrenalitis
- Tuberculosis
- Adrenalectomy
- Amyloidosis, hemochromatosis
• Clinical features:
- tiredness, weakness, lethargy
- Anorexia, nausea, vomiting
- Weight loss
- Postural hypotension
- Pigmentation (due to high ACTH)
- Loss of body hair
- Hypoglycemia, depression- less common
Secondary adrenal failure:
• Pituitary failure- decreased ACTH
• Other signs of hypopituitarism also present
• Abnormal pigmentation absent
Diagnosis
• Plamsa cortisol level (at 0900h)
- <50 nm0l/l- dxtic of adrenal failure
- >550 nmol/l- exclusion
- However, concn in majority cases lies in between
• Enzyme block-
Partial- marked/ subtle clinical features
Complete- incompatible with life
CAH
• Congenital presence of disorder
• Adrenal hyperplasia-
due to compensatory ACTH response to cortisol deficiency
• “Adrenogenital syndrome”
Affects genitalia and secondary sex characteristics of newborn
Enzymes affected:
• 21 hydroxylase deficiency: around 95 % cause
• 11 beta hydroxylase deficiency:about 5% cause
• Others: (rare)
- Steroid 3 beta hydroxy dehydrogenase
- Cholesterol hydroxylase/ side chain cleavage enzyme
- 17 hydroxylase
- 18 hydroxylase
• Incomplete deficiency common than complete block-
maintenance of adequate cortisol by compensatory ACTH
secretion (adrenal hyperplasia)
• Substrate of enzyme, 17 OH- progesterone accumulates –>
increased formation of adrenal androgens
• Females-
ambiguous genitalia (less common)
Late onset CAH: early adulthood- hirsuitism, amenorrhoea,
infertility
• Males-
Precocious puberty; accelerated growth
Complete enzyme deficiency:
• Less common
• life threatening condition; insufficient cortisol and
aldosterone to maintain homeostasis
Diagnosis:
- 17 OH progesterone
- Genetic analysis
Adrenal medulla:
• Production of Catecholamines
• No clinical sequel from decreased adrenal
medullary activity- not essential to life